Automate the pipeline
for your next radiopharmaceutical.
One modular AI workspace from target discovery to de-risking — reproducible workflows, no-code connections made simple, and reliable leads generated faster than ever.
A Complete Ecosystem for Scientific Discovery in Radiopharmaceutics
Creating the next radiopharmaceutical through deeper biological insights powered by AI.
Epitorix offers a modular platform using over 30 state-of-the-art AI models to design pharmaceutical leads. Apply individual modules or connect them into an end-to-end workflow — target discovery, binding-site analysis, molecular generation, affinity ranking, optimization, off-target prediction, cell-type risk, organ risk and biodistribution modeling.
- Reproducible workflows
- No-code connections made simple
- Generate reliable leads faster than ever
- Transparent process
We design your pipeline end to end
We design your pipeline end to end — from generating possible lead pharmaceuticals all the way to clinical-ready candidates, optimized to minimize the risk of failure at every stage.
- 1Generation
- 2Affinity
- 3Stability
- 4Toxicity
- 5Biodistribution
- 6Live platform
- 7Dashboard
Powered by Literature and Epitorix
Generator Engines — fifteen and counting.
Our In-House Models
We are not just combining published models — we have our own.
Best-in-class and first-in-class: architectures designed by Epitorix, trained on data we generated ourselves, and validated at the bench. They exist nowhere else.
- We built AI models beyond SOTA in designing peptide, antibody, nanobody, and mini-protein.
- Predicting binding affinity with Pearson correlation 0.84.
0%
hit rate across all experimentally validated designs
0.00
Pearson correlation predicting binding affinity
Epi-labs
Connect to 10+ labs across the United States to experimentally validate your compound with a single drag-and-drop.
Epitorix AI
A Specialized RAG System at Your Fingertips.
Build and Optimize Your Best Lead Compounds Using the Raw Power of Fable 5 and ChatGPT-5.6.
Eligible academics get unlimited access to Epitorix's top-tier models.
EPiQ™ compresses months of complex, PhD-level research into mere hours. By leveraging world-class, peer-reviewed generative AI models to design lead pharmaceuticals, workflows that once took my postdocs months for a single target are now fully automated and completed in just a couple of hours. Absolutely amazing.
Dr. Eliot Siegel, MD, FACR, FSIIM, DABR — Co-Founder of United Theranostics/FAQ
Clear Answers to Your Common Questions
EPiQ™ is Epitorix's modular AI workspace for target discovery, binding-site analysis, molecular generation, affinity ranking, optimization, off-target prediction, cell-type risk assessment, organ-risk prediction, and biodistribution modeling. Users can apply individual modules or connect them into an end-to-end workflow.
Meet Xenoclea
Xenoclea The Ultimate AI Orchestrator
Xenoclea is the conversational layer of EPiQ for scientists who want the power without the infrastructure: describe your target in plain language and it orchestrates Epitorix's models into ranked, structure-backed designs.
Contact
Bring us a target.
Move from disease biology to a collaborative end-to-end program—from target discovery through lead generation—combining Epitorix intelligence with the scientists guiding the development path.